Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,534.68
(
-1.09%
)
US TECH 100
23,397.00
(
-1.37%
)
Dow Jones
45,756.66
(
-0.58%
)
Brent Oil
107.39
(
2.83%
)
Bitcoin
69,574.00
(
-0.46%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Wednesday, 03/20/2013 8:27:24 AM

Wednesday, March 20, 2013 8:27:24 AM

Post# of 257262
Valeant Pharmaceuticals (VRX) has agreed to acquire Obagi Medical Products (OMPI) for $360M, with the $19.75/share offer representing a 42% premium to Obagi's closing price on Thursday last week, a day before it released its 2012 earnings results
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today